$EVEX
Eve Holding, Inc. Stock $evex

$evex Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000155485523000725 Filed on November 07, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.282M	$5.035M	$8.964M
YoY Change	-41.08%	-26.45%	575.25%
% of Gross Profit
Research & Development	$33.59M	$28.64M	$18.03M
YoY Change	86.33%	100.31%	35.75%
% of Gross Profit
Depreciation & Amortization	$44.00K	$40.00K	$24.88K
YoY Change	76.85%		-76.95%
% of Gross Profit
Operating Expenses	$40.74M	$33.68M	$26.99M
YoY Change	50.92%	59.27%	1933.19%
Operating Profit		-$33.68M
YoY Change		-12.68%
Interest Expense	$6.195M	$1.950M	$7.249M
YoY Change	-14.54%	-15.72%	-449.78%
% of Operating Profit
Other Income/Expense, Net	-$4.734M	$1.616M
YoY Change		201.18%
Pretax Income	-$39.27M	-$30.11M	-$19.74M
YoY Change	98.94%	-16.94%	480.61%
Income Tax	-$6.380K	$1.098M	$312.9K
% Of Pretax Income
Net Earnings	-$39.27M	-$31.21M	-$20.05M
YoY Change	95.8%	-15.06%	489.81%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	-$0.14	-$0.11	-$0.07
COMMON SHARES
Basic Shares Outstanding	269.4M shares	269.2M shares	266.4M shares
Diluted Shares Outstanding		275.9M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$158.1M	$174.5M	$227.9M
YoY Change	-30.64%	-29.72%	47850.44%
Cash & Equivalents	$46.88M	$10.10M	$49.15M
Short-Term Investments	$111.2M	$164.4M	$178.8M
Other Short-Term Assets	$889.0K	$1.586M	$1.426M
YoY Change	-37.64%	-46.67%	6643.17%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$242.2M	$259.6M	$312.2M
YoY Change	-22.42%	-22.08%	2035.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$547.0K	$477.9K	$451.6K
YoY Change	21.13%	14.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$348.0K	$976.5K	$0.00
YoY Change
Total Long-Term Assets	$3.118M	$1.989M	$668.2K
YoY Change	366.61%	375.05%	-4.51%
TOTAL ASSETS
Total Short-Term Assets	$242.2M	$259.6M	$312.2M
Total Long-Term Assets	$3.118M	$1.989M	$668.2K
Total Assets	$245.3M	$261.6M	$312.9M
YoY Change	-21.59%	-21.58%	1942.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.571M	$1.832M	$2.097M
YoY Change	117.97%	-38.16%	138.95%
Accrued Expenses		$9.800M	$2.492M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$51.99M	$46.16M	$24.93M
YoY Change	108.51%	64.75%	1533.86%
LONG-TERM LIABILITIES
Long-Term Debt	$25.76M	$11.32M	$0.00
YoY Change
Other Long-Term Liabilities	$2.535M	$2.000M	$1.020M
YoY Change	148.51%	138.42%	45.12%
Total Long-Term Liabilities	$28.30M	$13.35M	$1.020M
YoY Change	2674.21%	1491.17%	45.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.99M	$46.16M	$24.93M
Total Long-Term Liabilities	$28.30M	$13.35M	$1.020M
Total Liabilities	$80.29M	$59.51M	$25.95M
YoY Change	209.36%	106.22%	1064.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$344.7M	-$305.4M	-$217.0M
YoY Change	58.83%	55.06%
Common Stock	$509.7M	$507.4M	$503.9M
YoY Change	1.15%	1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$165.1M	$202.0M	$286.9M
YoY Change
Total Liabilities & Shareholders Equity	$245.3M	$261.6M	$312.9M
YoY Change	-21.59%	-21.58%	1942.61%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$39.27M	-$31.21M	-$20.05M
YoY Change	95.8%	-15.06%	489.81%
Depreciation, Depletion And Amortization	$44.00K	$40.00K	$24.88K
YoY Change	76.85%		-76.95%
Cash From Operating Activities	-$24.51M	-$22.40M	-$20.74M
YoY Change	18.2%	32.1%	3361.63%
INVESTING ACTIVITIES
Capital Expenditures	-$60.00	$0.00	$57.75K
YoY Change	-100.1%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$47.00M	-$12.00M	-$8.000M
YoY Change	-687.5%	-87.5%	247.83%
Cash From Investing Activities	$47.00M	-$12.00M	-$8.058M
YoY Change	-683.29%	-87.55%	250.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.21M	11.00M	0.000
YoY Change		-26.67%	-100.0%
NET CHANGE
Cash From Operating Activities	-24.51M	-22.40M	-20.74M
Cash From Investing Activities	47.00M	-12.00M	-8.058M
Cash From Financing Activities	14.21M	11.00M	0.000
Net Change In Cash	36.70M	-23.40M	-28.80M
YoY Change	-227.45%	-76.21%	4706.67%
FREE CASH FLOW
Cash From Operating Activities	-$24.51M	-$22.40M	-$20.74M
Capital Expenditures	-$60.00	$0.00	$57.75K
Free Cash Flow	-$24.51M	-$22.40M	-$20.80M
YoY Change	17.87%	35.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Income Loss NetIncomeLoss	-88391854	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	number
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	number
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001823652
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Company modified the service period for grants issued to certain grantees. The modification shortened the service period from three years to one year.
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39704
	dei	Entity Registrant Name EntityRegistrantName	EVE HOLDING, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2549808
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1400 General Aviation Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32935
	dei	City Area Code CityAreaCode	(321)
	dei	Local Phone Number LocalPhoneNumber	751-5050
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	269359021	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10097318	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49146063	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	164448485	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	178781549	usd
CY2023Q3	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	81805950	usd
CY2022Q4	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	82650375	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1586393	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	259562244	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	312207206	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477928	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	534733	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216636	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	976467	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1989128	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	668222	usd
CY2023Q3	us-gaap	Assets Assets	261551372	usd
CY2022Q4	us-gaap	Assets Assets	312875428	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1832288	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2097097	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13395000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3562500	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	46159081	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24933011	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11319690	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13347476	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1020074	usd
CY2023Q3	us-gaap	Liabilities Liabilities	59506557	usd
CY2022Q4	us-gaap	Liabilities Liabilities	25953085	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	269209	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	269094	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	503661571	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305400175	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-217008322	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	202044815	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922343	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	261551372	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	312875428	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28642065	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14298925	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	71991658	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33830890	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5034782	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6845045	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17822207	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23892011	usd
CY2023Q3	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
CY2022Q3	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	17424230	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	104776230	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-33676847	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-38568200	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89813865	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-162499131	usd
CY2023Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-853575	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	285000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-9832500	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6127500	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	2802189	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	1492292	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	9039037	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	2380240	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1616035	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	536562	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3789856	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	635180	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30112198	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36254346	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86817472	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153356211	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1097647	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490376	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1574382	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	620084	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-31209845	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
	us-gaap	Net Income Loss NetIncomeLoss	-88391854	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275887223	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275887223	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272040343	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272040343	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275671199	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275671199	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247010044	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-31209845	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
	us-gaap	Net Income Loss NetIncomeLoss	-88391854	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31209845	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36744722	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-88391854	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-153976295	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2022Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	732776	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	746537	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
CY2022Q2	evex	Increase Decrease Through Reclassification Of Public Warrants From Liability To Equity IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiabilityToEquity	10580000	usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	87352000	usd
CY2022Q2	evex	Stock Issued During Period Value Reverse Recapitalization Net Of Fees StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees	315326717	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1935988	usd
CY2022Q2	evex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	8000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1028182	usd
CY2022Q2	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	-2105409	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	307650450	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000000	usd
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	17424230	usd
CY2022Q3	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	653699	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	691909	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	304675566	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	867893	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	480000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	262498254	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	650075	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	231738303	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-31209845	usd
CY2023Q3	evex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1150	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1515207	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	202044815	usd
	us-gaap	Net Income Loss NetIncomeLoss	-88391854	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
	us-gaap	Depreciation Depreciation	141714	usd
	us-gaap	Depreciation Depreciation	0	usd
	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	54766	usd
	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1750	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	384791	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	53517	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3320330	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2589688	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	480000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	106496321	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-9832500	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6127500	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	5666936	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	1354049	usd
	evex	Interest Income On Related Party Loan Receivable InterestIncomeOnRelatedPartyLoanReceivable	-844425	usd
	evex	Interest Income On Related Party Loan Receivable InterestIncomeOnRelatedPartyLoanReceivable	638145	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	732745	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3263583	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	1898477	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-14814	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-256735	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2865325	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	8015787	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4641968	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4643734	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3575088	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69996532	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38702719	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	72500000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	52500000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	169000000	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	0	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	81000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	168056	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250418721	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11375385	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	375201	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	287154	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	369830250	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	15754066	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1372633	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1150	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10714180	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	352703551	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	401663	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-17263	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39048745	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	63564848	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49146063	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14376523	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10097318	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77941371	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	874810	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	489590	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	372863	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	usd
	us-gaap	Stock Issued1 StockIssued1	1365750	usd
	us-gaap	Stock Issued1 StockIssued1	1584800	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	220000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	699753	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	evex	Net Parent Investment NetParentInvestment	10731615	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21570673	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin: 0px; line-height: 107%; font-size: 11pt; font-family: Calibri, sans-serif; text-indent: 0px;"><b><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">Prior Period Reclassification</span></b></p> <p style="margin: 0pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0px; line-height: 107%; font-size: 11pt; font-family: Calibri, sans-serif; text-indent: 0px; text-align: justify;"><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">We have reclassified certain prior period amounts to conform to the current period presentation. Exchange rate effects due to translation were reclassified from line items within “Changes in operating assets and liabilities” to “Unrealized gain on exchange rate translation” and “<span style="color: #000000; line-height: inherit;">Effect of exchange rate changes on cash and cash equivalents</span>” within the condensed consolidated statements of cash flows.</span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 10pt; text-align: justify; text-indent: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 0px; text-align: justify; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-indent: 0px;"><span style="font-size: 10pt; font-family: 'Times New Roman', serif; line-height: inherit;"><span style="line-height: inherit;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. </span><span style="line-height: inherit;"><span style="line-height: inherit;">Under the legal entity approach, the significant estimates include, </span></span><span style="line-height: inherit;">but are not limited to the measurement of warrants, fair value measurement and income taxes.</span></span></p>
CY2023Q3	us-gaap	Cash Cash	5521119	usd
CY2022Q4	us-gaap	Cash Cash	14446534	usd
CY2023Q3	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4576199	usd
CY2022Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4483260	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	0	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	30216269	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10097318	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49146063	usd
CY2023Q3	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P90D
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	21620397	usd
CY2022Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	11829785	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	55521353	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	35263146	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	816405	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1292317	usd
CY2023Q3	us-gaap	Supplies Supplies	510805	usd
CY2022Q4	us-gaap	Supplies Supplies	0	usd
CY2023Q3	evex	Advances To Employees AdvancesToEmployees	209749	usd
CY2022Q4	evex	Advances To Employees AdvancesToEmployees	74064	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	0	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	34642	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	49434	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	24484	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1586393	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	600145	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	476465	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122217	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24879	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477928	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37220	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95979	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	9501382	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11723724	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	404034	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	11319690	usd
CY2023Q3	evex	Deferred Charges Related To Debt Issuance Costs DeferredChargesRelatedToDebtIssuanceCosts	384683	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269209021	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269209021	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269094021	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269094021	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-31209845	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275887223	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275887223	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272040343	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272040343	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275671199	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275671199	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247010044	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57945675	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57349750	shares
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.036	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.014	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.018	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1574382	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28642065	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14298925	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	71991658	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33830890	usd

Files In Submission

Name	View Source	Status
evex-20230930_cal.xml	Edgar Link	unprocessable
evex-20230930_def.xml	Edgar Link	unprocessable
0001554855-23-000725-index-headers.html	Edgar Link	pending
0001554855-23-000725-index.html	Edgar Link	pending
0001554855-23-000725.txt	Edgar Link	pending
0001554855-23-000725-xbrl.zip	Edgar Link	pending
evex-20230930.htm	Edgar Link	pending
evex-20230930.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
evex-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
evex-20230930_lab.xml	Edgar Link	unprocessable
evex-20230930_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVEX
Eve Holding, Inc. Stock $evex

2023 Q4 Form 10-Q Financial Statement

#000155485523000725 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX Eve Holding, Inc. Stock $evex

2023 Q4 Form 10-Q Financial Statement

#000155485523000725 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX
Eve Holding, Inc. Stock $evex